Clinical Trial

Voiceitt for People With Impairments in Speech

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-07; most recent amendment 2026-07-02.
Trial Details
NCT Number NCT06874322
Lead Sponsor University of Pittsburgh
Collaborators: Duquesne University
Conditions Speech Impairment, Speech Disorder
Enrollment 20 participants
Start Date 2025-06-25
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-06